Comparison of sprinkle versus syrup formulations of valproate for bioavailability, tolerance, and preference
- 1 April 1992
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 120 (4) , 634-638
- https://doi.org/10.1016/s0022-3476(05)82496-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Absorption Characteristics of a New Valproate Formulation: Divalproex Sodium‐Coated Particles in Capsules (Depakote® Sprinkle)The Journal of Clinical Pharmacology, 1990
- Diurnal Variation of Carbamazepine and Carbamazepine-10,11-epoxide in Plasma and Saliva in Children With Epilepsy: A Comparison Between Conventional and Slow-Release FormulationsJournal of Child Neurology, 1990
- How Often Is Medication Taken as Prescribed?JAMA, 1989
- Effect of food on the serum concentration profile of entericcoated valproic acidNeurology, 1988
- Valproic acid pharmacokinetics in children. II.Neurology, 1985
- Gastrointestinal tolerance of divalproex sodiumNeurology, 1983
- Clinical and pharmacokinetic observations on sodium valproate - A 5-year follow-up study in 100 children with epilepsyActa Neurologica Scandinavica, 1982
- Pharmacology of valproic acid in children with severe epilepsyNeurology, 1981
- Bioavailability of Valproic Acid Under Fasting/ Nonfasting RegimensThe Journal of Clinical Pharmacology, 1980
- The two‐period cross‐over clinical trial.British Journal of Clinical Pharmacology, 1979